Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension
- PMID: 26164465
- DOI: 10.1007/s11906-015-0579-4
Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension
Abstract
Patients with uncontrolled hypertension on adequate combination and doses of blood pressure-lowering drugs present a diagnostic and therapeutic dilemma. Currently, hypertension guidelines point out uncommon causes of hypertension (either organic such as secondary hypertension or drugs/substances interfering with blood pressure-lowering drugs or causing hypertension) as a cause of hypertension resistance. Non-adherence to drugs, however, is equally, if not more, a cause of hypertension resistance. True resistance to pharmacotherapy is relatively uncommon, as in the majority of patients with non-adherence and/or secondary hypertension, the diagnosis of the problem may potentially lead to better control. Conventionally applied indirect methods to detect non-adherence are inadequate to uncover all cases of non-adherence, especially intentional non-adherence. Rigorous methods to detect non-adherence including direct observed therapy and measuring drug/metabolite levels in body fluids should be considered simultaneously if not before costly and invasive investigations for patients with difficult to control hypertension. However, data on the effectiveness of whether diagnosing non-adherence ultimately controls hypertension is still awaited.
Similar articles
-
Adherence to antihypertensive therapy and therapeutic dosage of antihypertensive drugs.High Blood Press Cardiovasc Prev. 2016 Dec;23(4):341-345. doi: 10.1007/s40292-016-0158-z. Epub 2016 May 9. High Blood Press Cardiovasc Prev. 2016. PMID: 27160721 Review.
-
Resistant hypertension? Assessment of adherence by toxicological urine analysis.J Hypertens. 2013 Apr;31(4):766-74. doi: 10.1097/HJH.0b013e32835e2286. J Hypertens. 2013. PMID: 23337469
-
Managing 'resistance': is adherence a target for treatment?Curr Opin Nephrol Hypertens. 2014 Sep;23(5):439-43. doi: 10.1097/MNH.0000000000000045. Curr Opin Nephrol Hypertens. 2014. PMID: 25036746 Review.
-
Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy.Hypertens Res. 2011 Jan;34(1):87-90. doi: 10.1038/hr.2010.183. Epub 2010 Sep 30. Hypertens Res. 2011. PMID: 20882030
-
[Treatment options for resistant hypertension: from pseudoresistant to refractory hypertension].Ned Tijdschr Geneeskd. 2015;160:A9937. Ned Tijdschr Geneeskd. 2015. PMID: 27142503 Review. Dutch.
Cited by
-
Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.Br J Clin Pharmacol. 2018 Nov;84(11):2535-2543. doi: 10.1111/bcp.13706. Epub 2018 Aug 15. Br J Clin Pharmacol. 2018. PMID: 29971815 Free PMC article.
-
Drug Development for Hypertension: Do We Need Another Antihypertensive Agent for Resistant Hypertension?Curr Hypertens Rep. 2016 Apr;18(4):25. doi: 10.1007/s11906-016-0634-9. Curr Hypertens Rep. 2016. PMID: 26949263 Review.
-
Evidence of Nonadherence in Cases of Pseudoresistant Hypertension.Integr Blood Press Control. 2021 Feb 11;14:9-17. doi: 10.2147/IBPC.S264057. eCollection 2021. Integr Blood Press Control. 2021. PMID: 33603455 Free PMC article.
-
The Prevalence of Nonadherence in Patients With Resistant Hypertension: A Systematic Review Protocol.Can J Kidney Health Dis. 2019 Dec 25;6:2054358119897196. doi: 10.1177/2054358119897196. eCollection 2019. Can J Kidney Health Dis. 2019. PMID: 31903192 Free PMC article.
-
Rethinking Resistant Hypertension.J Clin Med. 2022 Mar 7;11(5):1455. doi: 10.3390/jcm11051455. J Clin Med. 2022. PMID: 35268545 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical